Bioequivalence Study of Diclofenac 150 mg XR: A Single-Dose, Randomized, Open Label, 2-Period Crossover Study in Healthy Adult Volunteers

ISSN Print: 2327-5081
ISSN Online: 2327-509X
www.scirp.net/journal/jbm
E-mail: [email protected]

Citations

"Bioequivalence Study of Diclofenac 150 mg XR: A Single-Dose, Randomized, Open Label, 2-Period Crossover Study in Healthy Adult Volunteers"
written by Evelyn Pena, Alfredo Inatti, Xenón Serrano Martin,
published by Journal of Biosciences and Medicines, Vol.11 No.11, 2023

has been cited by the following article(s):

[1]	Pharmacokinetics and Bioequivalence Evaluation of Two Rosuvastatin Calcium 20 mg Tablets: A Single Oral Dose, Randomized-Sequence, Open-Label …
	Journal of Biosciences and Medicines, 2024

[2]	Relative bioavailability study of ticagrelor in healthy subjects under fasting conditions
	American Journal of …, 2024

[1]	ADVANCEMENT OF DRIED BLOOD SPOT TECHNIQUE WITH REMDESIVIR BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION IN HUMAN BLOOD AS PER ICH M10 GUIDELINE Asian Journal of Pharmaceutical and Clinical Research, 2025 DOI:10.22159/ajpcr.2025v18i7.54759

[2]	BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF REMDESIVIR IN HUMAN PLASMA BY LC-MS/MS AS PER ICH M10 GUIDELINE International Journal of Applied Pharmaceutics, 2025 DOI:10.22159/ijap.2025v17i6.55897

[3]	Relative bioavailability study of ticagrelor in healthy subjects under fasting conditions American Journal of Pharmacotherapy and Pharmaceutical Sciences, 2024 DOI:10.25259/AJPPS_2024_008